Immunomodulation

BIOLOGICAL6 trials

Sponsors

Objectif Recherche Vaccins SIDA, University Hospital, Caen, Karolinska Institutet, The First Affiliated Hospital with Nanjing Medical University, Center National of Bioproducts (BioCen)

Conditions

AMLAllergyAutoimmune DiseasesAutoinflammatory SyndromeDysregulated Host ResponseGastric CancerHIV-1 InfectionImmunodeficiency

Phase 2

Therapeutic Intensification Plus Immunomodulation in HIV-infected Patients

CompletedNCT01019551

Objectif Recherche Vaccins SIDAHIV-1 Infection

Start: 2010-09-30End: 2013-02-28Updated: 2013-06-13

Phase II Trial of Neoadjuvant Thymalfasin, PD-1 Inhibitor, and Chemoradiotherapy for cStage III GEJ Adenocarcinoma

RecruitingNCT07277439

The First Affiliated Hospital with Nanjing Medical UniversityGastric Cancer

Start: 2025-12-16End: 2029-02-16Target: 48Updated: 2026-03-19

Phase 3

Biomodulin T Intramuscular for Thymus Hypoplasia in Children. Phase III

RecruitingRPCEC00000247

Center National of Bioproducts (BioCen)Thymus hypoplasia Thymic Hypoplasia

Start: 2018-12-03Target: 60Updated: 2026-08-10

Unknown Phase

Pre-emptive Immunomodulation After Allogeneic Stem Cell Transplantation in AML

University Hospital, CaenAML

Start: 2016-06-30End: 2020-01-31Target: 60Updated: 2019-04-22

Biomodulina T- CIMAvax-EGF-Advanced Non-Small Cell Lung Cancer-Adults

RecruitingRPCEC00000358

Center of Molecular Immunology (CIM)Non-small cell lung cancer

Start: 2019-02-21Updated: 2026-08-10

SYSTEMS-LEVEL ANALYSES OF IMMUNE DYSREGULATION

RecruitingNCT06248957

Karolinska InstitutetAllergy, Autoimmune Diseases, Autoinflammatory Syndrome +2

Start: 2024-01-01End: 2031-12-31Target: 500Updated: 2024-02-08

Related Papers

Assessment of non-classical lymphocyte populations in patients with advanced lung cancer treated with Biomodulina T following platinum-based chemotherapy

Exploration of Immunology2024-08-051 citations

Treatment intensification followed by interleukin-7 reactivates HIV without reducing total HIV DNA

AIDS2015-12-1763 citations